Obesity Paradox in Heart Failure with Mildly Reduced Ejection Fraction.

IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pragmatic and Observational Research Pub Date : 2024-03-05 eCollection Date: 2024-01-01 DOI:10.2147/POR.S444361
Marielen Reinhardt, Tobias Schupp, Mohammad Abumayyaleh, Felix Lau, Alexander Schmitt, Noah Abel, Muharrem Akin, Jonas Rusnak, Ibrahim Akin, Michael Behnes
{"title":"Obesity Paradox in Heart Failure with Mildly Reduced Ejection Fraction.","authors":"Marielen Reinhardt, Tobias Schupp, Mohammad Abumayyaleh, Felix Lau, Alexander Schmitt, Noah Abel, Muharrem Akin, Jonas Rusnak, Ibrahim Akin, Michael Behnes","doi":"10.2147/POR.S444361","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The study investigates the prognostic impact of body mass index (BMI) in patients hospitalized with heart failure with mildly reduced ejection fraction (HFmrEF).</p><p><strong>Background: </strong>Limited data regarding the prognostic impact of BMI in patients with HFmrEF is available.</p><p><strong>Methods: </strong>Consecutive patients with HFmrEF (ie, left ventricular ejection fraction 41-49% and signs and/or symptoms of HF) were retrospectively included at one institution from 2016 to 2022. Risk stratification was performed according to WHO-defined BMI groups. The primary endpoint was all-cause mortality at 30 months (median follow-up). Kaplan-Meier, uni- and multivariable Cox proportional regression analyses were applied for statistics.</p><p><strong>Results: </strong>1832 consecutive patients with HFmrEF were included with a median BMI of 26.7 kg/m<sup>2</sup> (IQR 24.0-30.8 kg/m<sup>2</sup>). Patients with lowest BMI (ie, 18.5-24.9 kg/m<sup>2</sup>) were associated with highest risk of all-cause mortality at 30 months compared to patients with higher BMI values (40.0% vs 29.0% vs 21.4% vs 20.9%; log rank p = 0.001; HR = 0.721; 95% CI 0.656-0.793; p = 0.001). Even after multivariable adjustment, higher BMI values were associated with improved survival at 30 months (HR = 0.963; 95% CI 0.943-0.985; p = 0.001). In contrast, the risk of HF- related rehospitalization at 30 months was not affected by BMI (log rank p = 0.064).</p><p><strong>Conclusion: </strong>In patients hospitalized with HFmrEF, lower BMI was associated with increased risk of all-cause mortality at 30 months, suggesting an obesity paradox in HFmrEF.</p>","PeriodicalId":20399,"journal":{"name":"Pragmatic and Observational Research","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933520/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pragmatic and Observational Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/POR.S444361","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The study investigates the prognostic impact of body mass index (BMI) in patients hospitalized with heart failure with mildly reduced ejection fraction (HFmrEF).

Background: Limited data regarding the prognostic impact of BMI in patients with HFmrEF is available.

Methods: Consecutive patients with HFmrEF (ie, left ventricular ejection fraction 41-49% and signs and/or symptoms of HF) were retrospectively included at one institution from 2016 to 2022. Risk stratification was performed according to WHO-defined BMI groups. The primary endpoint was all-cause mortality at 30 months (median follow-up). Kaplan-Meier, uni- and multivariable Cox proportional regression analyses were applied for statistics.

Results: 1832 consecutive patients with HFmrEF were included with a median BMI of 26.7 kg/m2 (IQR 24.0-30.8 kg/m2). Patients with lowest BMI (ie, 18.5-24.9 kg/m2) were associated with highest risk of all-cause mortality at 30 months compared to patients with higher BMI values (40.0% vs 29.0% vs 21.4% vs 20.9%; log rank p = 0.001; HR = 0.721; 95% CI 0.656-0.793; p = 0.001). Even after multivariable adjustment, higher BMI values were associated with improved survival at 30 months (HR = 0.963; 95% CI 0.943-0.985; p = 0.001). In contrast, the risk of HF- related rehospitalization at 30 months was not affected by BMI (log rank p = 0.064).

Conclusion: In patients hospitalized with HFmrEF, lower BMI was associated with increased risk of all-cause mortality at 30 months, suggesting an obesity paradox in HFmrEF.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
射血分数轻度降低的心力衰竭患者的肥胖悖论
研究目的该研究调查了体重指数(BMI)对射血分数轻度降低的心力衰竭(HFmrEF)住院患者的预后影响:有关体重指数对射血分数轻度降低型心力衰竭患者预后影响的数据有限:方法:回顾性纳入2016年至2022年一家机构的连续HFmrEF患者(即左心室射血分数41%-49%且有HF体征和/或症状)。根据世卫组织定义的体重指数分组进行风险分层。主要终点是随访30个月(中位数)的全因死亡率。采用卡普兰-梅耶、单变量和多变量考克斯比例回归分析进行统计:共纳入 1832 名连续的 HFmrEF 患者,中位体重指数为 26.7 kg/m2(IQR 24.0-30.8 kg/m2)。与 BMI 值较高的患者相比,BMI 值最低的患者(即 18.5-24.9 kg/m2)在 30 个月内的全因死亡风险最高(40.0% vs 29.0% vs 21.4% vs 20.9%;对数秩 p = 0.001;HR = 0.721;95% CI 0.656-0.793; p = 0.001)。即使经过多变量调整,较高的 BMI 值也与 30 个月的生存率提高有关(HR = 0.963;95% CI 0.943-0.985;P = 0.001)。相比之下,30 个月后与心房颤动相关的再住院风险不受 BMI 的影响(对数秩 p = 0.064):结论:在HFmrEF住院患者中,较低的体重指数与30个月后全因死亡风险增加有关,这表明HFmrEF存在肥胖悖论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pragmatic and Observational Research
Pragmatic and Observational Research MEDICINE, GENERAL & INTERNAL-
自引率
0.00%
发文量
11
期刊介绍: Pragmatic and Observational Research is an international, peer-reviewed, open-access journal that publishes data from studies designed to closely reflect medical interventions in real-world clinical practice, providing insights beyond classical randomized controlled trials (RCTs). While RCTs maximize internal validity for cause-and-effect relationships, they often represent only specific patient groups. This journal aims to complement such studies by providing data that better mirrors real-world patients and the usage of medicines, thus informing guidelines and enhancing the applicability of research findings across diverse patient populations encountered in everyday clinical practice.
期刊最新文献
Improving the Transparency and Replicability of Consensus Methods: Respiratory Medicine as a Case Example. Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy. Comparing Machine Learning and Advanced Methods with Traditional Methods to Generate Weights in Inverse Probability of Treatment Weighting: The INFORM Study. Involvement of Root Canal Treatment in Pro-Inflammatory Processes - A Real-World Study. UK Electronic Healthcare Records for Research: A Scientometric Analysis of Respiratory, Cardiovascular, and COVID-19 Publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1